Jennifer Teti
Senior Director, Clinical Research
IMV Inc. (Dartmouth, Nova Scotia, Canada)

Summary of Qualifications
25+ years in the pharmaceutical industry. Unique blend of in-house and field experience across both early and late development including registrational studies. Experience with both in-sourced and out-sourced programs. Resourceful and engaged program leader with a strong and trusted operational voice who works well cross-functionally and is committed to quick problem-solving. Direct and honest line manager. Strong therapeutic area experience in Oncology, CNS, Immunology, Respiratory, and Rare Disease.
Experience
IMV, Inc. 3/2022 to present
• Senior Director, Clinical Research
Accountable for the delivery of a heme onc out-sourced program.
Janssen 10/2014 to 3/2022
• Director, Global Program Leader – Early Development, Oncology (1/2019 – 3/2022)
• Director, Global Program Leader – Early Development, Immunology (10/2017 – 12/2018)
Focus: Solid tumor, neoantigen vaccines, lung cancer and colorectal cancer interception space. Rare Diseases -
Familial Adenomatous Polyposis and Myeloproliferative Neoplasms.
Accountable for the delivery of early development programs in cancer and rare disease. Including robust
operational planning while ensuring strategic alignment of operational plan with business goals and therapeutic
area/programs objectives, and leading the clinical cross functional matrix team. High level of collaboration
required to leverage insights from KOLs, patient advisory boards, and advocacy groups and understand the
landscape in rare diseases and indications.
Directly supervised a team of Global Trial Leaders, ensuring consistencies across trials, and leveraging synergies
and innovative approaches across all programs. Accountable for ensuring team has robust goals and objectives.
Responsible for providing actionable feedback on a regular basis.
Spearheaded and supported Portfolio Delivery Operations Donates (surplus ancillary supply donation program)
with MAP International and IHP. Since 3Q2018, PDO has donated $1M+ of supplies that would otherwise have
been destroyed at the end of studies.
• Associate Director, Global Trial Leader – Early Development, Oncology (12/2015-10/2017)
Responsible for the successful cross-functional delivery of a Phase I dose escalation/expansion trial in
advanced stage solid tumor cancers, within agreed timelines and budget, and in alignment with all
applicable SOPs and regulatory requirements.
• Global Trial Manager – Early Development, Oncology (10/2014-12/2015)
Converted to a headcount position in June 2015. Responsible for the management, planning, and
coordination of a Phase II POC AML study (end-to-end) – involving 8 countries, 40 sites, 120+ subjects.
Handed study over to Late Development when it was amended to become potentially registrational.
Roche (became Genentech in the US) 6/2006 to 9/2014
• Lead Field Clinical Trial Monitor
Converted to a headcount position in 2007. Lead monitor for a Phase II POC autism study (later received
break-through designation) and for a Phase IIIb rheumatoid arthritis trial. Also monitored Phase I oncology (2
AML trials) and Phase III rheumatoid arthritis.
Shire 3/2005 to 6/2006
• Clinical Program Manager - CNS
AstraZeneca 9/2000 to 3/2005
• Clinical Study Leader – Respiratory (6/2003 to 3/2005)
• Clinical Research Manager – Respiratory (11/2002 to 6/2003)
• Sr. Clinical Research Scientist – Respiratory (10/2001 to 11/200211/2002)
• Clinical Quality Advisor – Worldwide Clinical Quality Assurance (9/2000 to 10/2001)
Merck 5/1998 to 9/2000
• Sr. Clinical Quality Assurance Auditor – Quality Assurance (9/1999 to 9/2000)
• Medical Research Coordinator (CRA) (5/1998 to 8/1999)
Zeneca 10/1995 to 2/1998
• Clinical Research Associate II – Pulmonary Therapeutics
HL Yoh Scientific (at Merck) 5/1995-9/1995
• Regulatory Coordinator – Worldwide Regulatory Coordination
Yale University Medical School 1993 to 1995
• Research Assistant – Anxiety Clinic (7/1994 to 4/1995)
• Research Aide – Depression Clinic (12/1993 to 5/1994, part-time student job)
Certifications
Certified Clinical Research Associate, ACRP 1997
• Certification Number A97340 (expired)
Education
Yale University, New Haven, CT 9/1990 to 5/1994
• BA, Psychology
Activities: Women’s Soccer
Awards: Second Team Division I All-America and Ivy League Player of the Year (1992 & 1993)
Volunteer Activities
Philadelphia Zoo, Philadelphia PA 9/2018 to present
• Docent (Class of 2019)
CONTACT
For more information about your participation, please contact us at info@clinicaltrialsymposium.com
For additional information regarding partnership, sponsors & exhibitors and media, please contact our marketing and communication department
at diana.lupu@avantyo.com or +40 (0) 726 840 456